EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Gut Microbiota in Ischemic Stroke: Role of Gut Bacteria-Derived Metabolites

Wei Zhang, Xiao Yu Dong, Rui Huang

Translational Stroke Research · 2023-12 · 14 (6) · 811-828

DOI: 10.1007/s12975-022-01096-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Translational Stroke Research, online erschienen am 24.10.2022. Verfasst von Wei Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Ischemic Stroke, Stroke. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 195 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ischemic stroke (IS) remains a leading cause of death and long-term disability globally. Several mechanisms including glutamate excitotoxicity, calcium overload, neuroinflammation, oxidative stress, mitochondrial damage, and apoptosis are known to be involved in the pathogenesis of IS, but the underlying pathophysiology mechanisms of IS are not fully clarified. During the past decade, gut microbiota were recognized as a key regulator to affect the health of the host either directly or via their metabolites. Recent studies indicate that gut bacterial dysbiosis is closely related to hypertension, diabetes, obesity, dyslipidemia, and metabolic syndrome, which are the main risk factors for cardiovascular diseases. Increasing evidence indicates that IS can lead to perturbation in gut microbiota and increased permeability of the gut mucosa, known as "leaky gut," resulting in endotoxemia and bacterial translocation. In turn, gut dysbiosis and impaired intestinal permeability can alter gut bacterial metabolite signaling profile from the gut to the brain. Microbiota-derived products and metabolites, such as short-chain fatty acids (SCFAs), bile acids (BAs), trimethylamine N-oxide (TMAO), lipopolysaccharides (LPS), and phenylacetylglutamine (PAGln) can exert beneficial or detrimental effects on various extraintestinal organs, including the brain, liver, and heart. These metabolites have been increasingly acknowledged as biomarkers and mediators of IS. However, the specific role of the gut bacterial metabolites in the context of stroke remains incompletely understood. In-depth studies on these products and metabolites may provide new insight for the development of novel therapeutics for IS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeIschemic StrokeStrokeHumansDysbiosisBacteria

Stichwörter der Autor:innen

Bile acidsIschemic strokeLipopolysaccharidesPhenylacetylglutamineShort-chain fatty acidsTrimethylamine N-oxide

Autor:innen und Institutionen

  • Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, China. huangr_cmu@163.com.

Zitieren

APA

Zhang, W., Dong, X. Y., & Huang, R. (2023). Gut Microbiota in Ischemic Stroke: Role of Gut Bacteria-Derived Metabolites. Translational Stroke Research, 14(6), 811-828. https://doi.org/10.1007/s12975-022-01096-3

Vancouver

Zhang W, Dong XY, Huang R. Gut Microbiota in Ischemic Stroke: Role of Gut Bacteria-Derived Metabolites. Translational Stroke Research. 2023;14(6):811-828. doi:10.1007/s12975-022-01096-3

BibTeX
@article{Zhang2023,
  author = {Zhang, Wei and Dong, Xiao Yu and Huang, Rui},
  title = {Gut Microbiota in Ischemic Stroke: Role of Gut Bacteria-Derived Metabolites},
  journal = {Translational Stroke Research},
  year = {2023},
  volume = {14},
  number = {6},
  pages = {811--828},
  doi = {10.1007/s12975-022-01096-3}
}
Kostenlos starten →